Navigation Links
Rejection Rate for Liver Transplants Patient Reduced

The dawn of the New Year has brought with it a new lease of life for Organ transplant patients who have liver failure. For these //patients the uphill struggle doesn’t stop with finding a matching donor. In fact it would have just started.

Research has shown that despite all high tech matching done for liver transplant patients, organ rejection is still a common phenomenon. Transplant surgeon Ignazio Marino, M.D., of Thomas Jefferson University Hospital in Philadelphia, says that rejection happens in at least 40 percent of patients undergoing a liver transplant. A new medical breakthrough has shown that the combination of certain drugs has been able to reduce the chances of rejection among liver transplant.

Dr. Marino and a team of researchers studied the effect of two anti-rejection drugs, Basiliximab and Tacrolimus. The medications were given to 50 liver transplant patients over a course of time.

"These two drugs, used in combination, allowed us to have a significant decrease in the rejection," Dr. Marino announced. "We went from about 40 percent rejection to only 12 percent."

Dr. Marino says this treatment is a sign of good things to come. "A transplant is not any longer a treatment to save a life momentarily. It is a treatment to give an excellent quality of life back to our patients."

Both drugs have been FDA approved and have minimal side affects.


Page: 1

Related medicine news :

1. A Urine Test Could Predict Rejection In Transplant Patients
2. Peer Rejection Leads To Reduced Participation In Classroom Activities
3. Inhaled Cyclosporine Results In Rejection Free Survival among Lung Transplant Patients
4. Low Dose Anti Rejection Protocol Helps Intestinal Transplant Recipients
5. Survey Reveals Rejection of NHS Database Scheme
6. Ontario Supports OHIP’s Rejection of Claim by North York Ma
7. Stem Cell Finding Could Help Reduce Transplant Rejection
8. Blood Cells Capable of Regenerating Liver
9. Liver donors can thrive after transplant
10. Heavy Drinking Raises Risk of Liver Cancer
11. Arthritis Drug May Cause Liver Damage
Post Your Comments:

(Date:11/30/2015)... ... November 30, 2015 , ... ... by UPMC and KingMed Diagnostics researchers. Their review of ... that consultation with UPMC pathologists resulted in significantly altered treatment plans for more ...
(Date:11/30/2015)... ... 30, 2015 , ... ”Dying Words: The AIDS Reporting of Jeff Schmalz and ... to coincide with World AIDS Day. The multi-media project will be in audio documentary ... as he was dying of the disease. , A collaborative effort led by author, ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... promoting breast and prostate cancer education and prevention—is joining forces with the award-winning ... philanthropy and Hollywood elegance on December 7, 2015 at the Union League of ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... their exclusive channel partner for the Nutraceutical Specialties products into oral solid dosage ... effective immediately. , “We are pleased to announce our expanded distribution agreement ...
(Date:11/30/2015)... ... November 30, 2015 , ... California-based i2i ... years, announced today that Michigan-based Family Health Center (FHC) has selected i2iTracks as ... years, FHC was awarded the largest Affordable Care Act grant for Federally Qualified ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... YORK , Nov. 30, 2015 Cumberland Pharmaceuticals ... will present live at on December 3, 2015. ... --> TIME: 3:15p.m. ET LINK: ... ET LINK: --> ... online event where investors are invited to ask the company ...
(Date:11/30/2015)... Nov. 30, 2015 Varian Medical Systems (NYSE: VAR ... educational partnership with Apollo Hospitals Group, the largest hospital chain in ... help train radiation technologists in the country. The MoU was signed ... Knowledge, and Ashok Kakkar , Varian,s India ... India , Varian intends to deploy its Access ...
(Date:11/30/2015)... and BOSTON , November 30, 2015 ... develop potential new medicines directed at up to 10 ... --> PFE ) to research and develop ... protein-coupled receptor (GPCR) targets across multiple therapeutic areas. ... drug discovery and development company and wholly-owned subsidiary of ...
Breaking Medicine Technology: